Immune Responses Flashcards
IgG
Main antibody in 2° response to an antigen. Most abundant isotype in serum. Fixes complement, opsonizes bacteria, neutralizes bacterial toxins and viruses. Only isotype that crosses the placenta (provides infants with passive immunity).
IgA
Prevents attachment of bacteria and viruses to mucous membranes; does not fix complement. Monomer (in circulation) or dimer (with J chain when secreted). Crosses epithelial cells by transcytosis. Produced in GI tract (eg, by Peyer patches) and protects against gut infections (eg, Giardia). Most produced antibody overall, but has lower serum concentrations. Released into secretions (tears, saliva, mucus) and breast milk. Picks up secretory component from epithelial cells, which protects the Fc portion from luminal proteases
IgM
Produced in the 1° (immediate) response to an antigen. Fixes complement. Cannot cross the placenta. Antigen receptor on the surface of B cells. Monomer on B cell, pentamer with J chain when secreted. Pentamer enables avid binding to antigen while humoral response evolves.
IgD
Unclear function. Found on surface of many B cells and in serum
IgE
Binds mast cells and basophils; cross-links when exposed to allergen, mediating immediate (type I) hypersensitivity through release of inflammatory mediators such as histamine. Contributes to immunity to parasites by activating eosinophils. Lowest concentration in serum
Classic Complement Pathway
IgG or IgM mediated
Alternative Complement Pathway
microbe surface molecules
Lectin Complement Pathway
mannose or other sugars on microbe surface
C3b functions
opsonization
C3a, C4a, C5a functions
anaphylaxis
C5a functions
neutrophil chemotaxis
C5b-9 functions
cytolysis by MAC
Opsonins functions
C3b and IgG are the two 1° opsonins in bacterial defense; enhance phagocytosis. C3b also helps clear immune complexes.
Inhibitors functions
decay-accelerating factor (DAF, aka CD55) and C1 esterase inhibitor help prevent complement activation on self cells (eg, RBCs).
Early complement deficiencies (C1-C4)
Increased risk of severe, recurrent pyogenic sinus and respiratory tract infections. Increased risk of SLE